Client
- Name
- IOVANCE BIOTHERAPEUTICS, INC.
- Description
- Development and commercialization of immunotherapies
- Location
- California · United States of America
Registrant
- Firm
- AVENUE SOLUTIONS
- Description
- Government representation
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Issues related to H.R. 5376, Inflation Reduction Act of 2022 (now PL 117-169) and implementation; Issues related to the Continuing Resolution, H.R. 6833; Education around tumor infiltrating lymphocytes (TIL) cancer therapies; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Issues related to accelerated approval; Issues related to the FY 2023 President's Budget; CMS Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Rates Proposed Rule for FY 2023; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
LobbyistsTRACY SPICER · ms ELIZABETH MACDONALD BARNETT
TargetedSENATE · HOUSE OF REPRESENTATIVES